Otologic Pharmaceutics, Inc.

Otologic Pharmaceutics, Inc.

Otologic Pharmaceutics, Inc.

Overview
Date Founded

2009

Headquarters

865 Research Parkway,PHF Research Park,Suite 400,Oklahoma City, OK 73104

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Pharmaceuticals
IT Consulting & Services
Holding Companies
Biotechnology

Company Description

Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK.

Website

http://www.otologicpharmaceutics.com

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Richard Kopke

Co-Founder

Robert A. Floyd

Co-Founder

Clayton I. Duncan

Chairman & Chief Executive Officer

Richard E. Gammans

President & Chief Operating Officer

Kelle Jones

Chief Financial Officer

Board of Directors
Clayton I. Duncan

Chairman of the Board, Chief Executive Officer, Founder at Synereca Pharmaceuticals, Inc.

Trending People
United States Environmental Protection Agency
Saia LTL Freight Deploys Company’s First All-Electric Tractors in its North Amer... - GlobeNewswire
Dow, Inc.
Dow and Mura Technology Announce Partnership to Scale Game-changing New Advanced... - CSRwire
Southwest Airlines Co.
US STOCKS-U.S. stock sink on reports of Biden tax proposals - Nasdaq
HCA Healthcare, Inc.
Notable Thursday Option Activity: ZS, NET, HCA - Nasdaq
AT&T, Inc.
AT&T’s 1Q Results Beat Estimates; Shares Up 5% - Nasdaq
Trending Organizations
United States Environmental Protection Agency
Saia LTL Freight Deploys Company’s First All-Electric Tractors in its North Amer... - GlobeNewswire
Dow, Inc.
Dow and Mura Technology Announce Partnership to Scale Game-changing New Advanced... - CSRwire
Southwest Airlines Co.
US STOCKS-U.S. stock sink on reports of Biden tax proposals - Nasdaq
HCA Healthcare, Inc.
Notable Thursday Option Activity: ZS, NET, HCA - Nasdaq
AT&T, Inc.
AT&T’s 1Q Results Beat Estimates; Shares Up 5% - Nasdaq
Paths to Otologic Pharmaceutics, Inc.
Potential Connections via
Relationship Science
You
Otologic Pharmaceutics, Inc.
Investors
Details Hidden
Accele Venture Management LLC

Accele Venture Management LLC is a venture capital firm located in Oklahoma City, Oklahoma.

Details Hidden
i2E, Inc.

i2E focuses on investments in advanced technology companies that will further economic development in Oklahoma. They invest across a variety of stages including proof-of-concept, seed and early-stage. i2E is often the first external investor in their portfolio companies. Initial investments range from $100,000 at the proof-of-concept stage. Seed and early-stage investments range from $250,000 to $700,000. Investments are made as refundable awards at the proof-of-concept stage and as convertible debt or straight equity at the seed and start-up stages.

Details Hidden
INTEGRIS Health, Inc.

INTEGRIS Health, Inc. provides health care services. It operates hospitals, rehabilitation centers, physician clinics, mental health facilities, independent living centers, and home health agencies. The firm offers cardiac care, obesity and bariatric surgery, breast care, children's health, dermatology, digestive health, fitness, hand surgery, heart care, home care, hospice, mental health, neurosciences, orthopedics, radiology, surgical, urology, women's health, and sleeping disorder services. The company was founded in 1983 and is headquartered in Oklahoma City, OK.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Otologic Pharmaceutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Otologic Pharmaceutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Otologic Pharmaceutics, Inc..